| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $4.3M | +21.2% |
| SG&A Expense | $4.9M | +3.4% |
| Operating Income | -$9.2M | -11.0% |
| Interest Expense | $400K | +100.0% |
| Net Income | -$8.5M | -3.5% |
| EPS (Basic) | -$0.25 | +21.9% |
| EPS (Diluted) | -$0.25 | +21.9% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.6M | +275.8% |
| Current Assets | $12.0M | +241.0% |
| Total Assets | $12.1M | +198.2% |
| Total Liabilities | $488K | +87.2% |
| Stockholders' Equity | $11.7M | +205.8% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.3M | +21.5% |
| Financing Cash Flow | $14.9M | — |